Actelion Pharmaceuticals Ltd

Type: Company
Name: Actelion Pharmaceuticals Ltd (Actelion Ltd)
Nationality: Switzerland
Web Address: http://www.actelion.com/
Fact Sheet: Fact Sheet for Actelion Ltd
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Actelion Q3 net income up

Actelion Ltd, a biopharmaceutical company, has reported that net income for the third quarter ended September 30, 2014 was CHF145.6 million, or CHF1.25 per diluted share, compared to of CHF105.02 million, or CHF0.92 per diluted share, for the same quarter ... [Published Individual.com - 1 hour ago]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Actelion reports higher sales, earnings

Switzerland’s Actelion Ltd, which has a portfolio of treatments for pulmonary arterial hypertension (PAH), reported significantly higher sales and earnings for the third quarter and the first nine months of 2014.LocationSwitzerland ... [Published MedNous - Oct 23 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 2 reports

ACTELION : Europe

STOCKS advanced yesterday after companies including Actelion and Swedbank posted better-than-estimated earnings, while the European Central Bank (ECB) was said to have bought Italian covered bonds.The Stoxx Europe 600 index climbed 2.1 percent to 323.74 ... [Published 4 Traders - Oct 22 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 1 reports

ISEQ jumps as heavyweights surge

The ISEQ surged yesterday as some of the biggest companies on the benchmark jumped amid unconfirmed reports that the European Central Bank bought Italian- covered bonds. The ISEQ surged yesterday as some of the biggest companies on the benchmark jumped ... [Published Irish Independent - Oct 22 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 1 reports

Global advances on technology earnings

After a dose of the horrors last week, global markets advanced yesterday as American shares were buoyed by technology earnings and the prospect of corporate bond purchases by the European Central Bank led European stocks back into positive territory.A ... [Published Irish Times - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 2 reports

Canadian Dollar Advances As European Stocks Oil Prices Rise

RTT News Wednesday 22nd October, 2014The Canadian dollar strengthened against its major rivals in European deals on Tuesday, amid risk appetite and an increase in oil prices after better-than-expected China GDP data for the third quarter.Crude for December ... [Published Canada Standard - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 2 reports

Actelion's (ALIOF) CEO Jean-Paul Clozel on Q3 2014 Results - Earnings Call Transcript

Actelion Limited ( OTCPK:ALIOF ) Q3 2014 Earnings Conference Call October 21, 2014 8:00 AM ETOperatorGood afternoon. This is the Arkadin conference operator. Welcome to the Actelion’s Nine Months 2014 Financial Results Conference Call. As a reminder, ... [Published Seeking Alpha - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 3 reports

Europe close: Stocks rise on reports of ECB bond buying

European stocks surged on Tuesday on the back of reports indicating that the European Central Bank may expand its programme of asset purchases to include corporate bonds and following the release of slightly stronger-than-expected economic data overnight ... [Published BullBearings - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Swiss Stocks Follow European Markets Sharply Higher, Led By Actelion

Swiss stocks rallied Tuesday, further trimming significant losses from earlier this month, as relatively upbeat Chinese GDP data soothed fears about the global economy.Among notable gainers, Actelion rose 3 percent as the drug maker posted better-than-expected ... [Published RTTNews.com - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Actelion (ALIOF) Announces Quarterly Earnings Results, Beats Expectations By $0.11 EPS

Actelion (NASDAQ:ALIOF) issued its quarterly earnings data on Tuesday. The company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.50 by $0.11, reports. Shares of Actelion (NASDAQ:ALIOF) traded up 1.35% on ... [Published American Banking News - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 15 reports

It's back to basics in M&A, and that's a good thing, Actelion CEO says

Swiss drugmaker hikes forecast again on strong Opsumit launchShareToolsAt least one potential tax-inversion buyout target is pretty happy about the new deal-quashing rules: Actelion CEO Jean-Paul Clozel. In fact, he says, the slap at inversions is not ... [Published FiercePharma - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 2 reports

UPDATE: European stocks gain on ECB talk, earnings

The advances came following a turbulent trading day on Monday, when major benchmarks closed with sharp losses. Last week, many indexes slumped to one-year lows amid concerns the eurozone could slip back into recession after Germany showed renewed signs ... [Published Morningstar.com - Oct 21 2014]

Quotes

...49 billion, compared to CHF1.32 billion for the same period ended September 30, 2013. Otto Schwarz, COO of Actelion, commented: "With sales of CHF59 million during the third quarter 2014, Opsumit's strong launch momentum continues as we gain ERA market share and continue to roll out the product in all major markets. Opsumit's highly differentiated label drives its rapid adoption in daily medical practice. By the end of the third quarter, Opsumit was available to patients in 16 markets including the most recent additions: Australia, Belgium, Iceland, Italy, and Luxembourg."
"Focus may go back to the micro, the corporate, as we get into the meat of reporting season" said James Buckley , a Baring Asset Management portfolio manager. - Bloomberg
...as we get into the meat of the reporting season," said James Buckley, who helps oversee about $48bn as a portfolio manager at Baring in London. "The quarter reported may be tough because of the global and geopolitical uncertainty, but guidance will be crucial and that'll have some tailwinds in terms of lower commodity prices and weaker euro."
Commenting on the company's figures, Morgan Stanley said in a research note: "We see strong iPhone demand, gross margin expansion, and under-ownership driving upside to shares. Results and guidance were better than expected despite FX headwinds pressuring estimates across large-cap tech."

More Content

All (134) | News (103) | Reports (0) | Blogs (26) | Audio/Video (0) | Fact Sheets (2) | Press Releases (1)
sort by: Date | Relevance
Actelion Q3 net income up [Published Individual.com - 1 hour ago]
Museum der Kulturen by Herzog & de Meuron [Published IconEye.com - Oct 23 2014]
Actelion reports higher sales, earnings [Published MedNous - Oct 23 2014]
ACTELION : Europe [Published 4 Traders - Oct 22 2014]
Actelion Ltd raises FY 2014 core earnings outlook [Published Reuters - Oct 22 2014]
ISEQ jumps as heavyweights surge [Published Irish Independent - Oct 22 2014]
Global advances on technology earnings [Published Irish Times - Oct 22 2014]
European Stocks Rise as Actelion, Swedbank Earn... [Published Bisnis Indonesia - Oct 22 2014]
Canadian Dollar Advances As European Stocks Oil... [Published Canada Standard - Oct 21 2014]
Actelion's (ALIOF) CEO Jean-Paul Clozel on Q3 2... [Published Seeking Alpha - Oct 21 2014]
Actelion beats expectations as third-qtr net pr... [Published Pharma Letter - Oct 21 2014]
Europe close: Stocks rise on reports of ECB bon... [Published BullBearings - Oct 21 2014]
Swiss Stocks Follow European Markets Sharply Hi... [Published RTTNews.com - Oct 21 2014]
U.S. Stocks Extend Rally on Earnings, ECB Specu... [Published Washington Post - Oct 21 2014]
Actelion (ALIOF) Announces Quarterly Earnings R... [Published American Banking News - Oct 21 2014]
Dubai index ends near 1-week high [Published Gulf News - Oct 21 2014]
It's back to basics in M&A, and that's a good t... [Published FiercePharma - Oct 21 2014]
UPDATE: European stocks gain on ECB talk, earnings [Published Morningstar.com - Oct 21 2014]
European Markets Move Higher After Positive Cor... [Published TheStreet.com - Oct 21 2014]
BioSpecifics Technologies Corp. Announces FDA A... [Published Myrtle Beach Sun News - Oct 21 2014]
Actelion Reports Strong Q3 Results, Says It Has... [Published Bidness Etc - Oct 21 2014]
Europe midday: Stocks rise as ECB purchases Ita... [Published BullBearings - Oct 21 2014]
Latest Central Bank Sticksave Halts Futures Sli... [Published Zero Hedge - Oct 21 2014]
European shares rally on report ECB mulling cor... [Published London South East - Oct 21 2014]
Latest Central Bank Sticksave Halts Futures Sli... [Published Zero Hedge - Oct 21 2014]
European Stocks Rise as Corporate Earnings Over... [Published TheStreet.com - Oct 21 2014]
Canadian Dollar Advances As European Stocks, Oi... [Published London South East - Oct 21 2014]
European Market Update: Europe Endures Another ... [Published Action Forex - Oct 21 2014]
European Stock Markets Edge Higher [Published 4 Traders - Oct 21 2014]
Europe Stocks Gain as S&P 500 Futures Erase Los... [Published Bisnis Indonesia - Oct 21 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Latest Central Bank Sticksave Halts Futures Sli... [Published Zero Hedge - Oct 21 2014]
Another day, another central bank sticksave. Moments after Europe's open, when once again the equity futures complex was threatening to break the upward trendline, after USDJPY took out stops and sliding below 106.3, pushing bonds both in Europe and ...
Rigontec raises $11.95 mln [Published PE Hub Blog - Oct 14 2014]
Rigontec GmbH said Tuesday it raised €9.45 million (US$11.95 million) in a first close of a Series A round co-led by Wellington Partners and Boehringer Ingelheim Venture Fund . Other investors include NRW Bank and High-Tech Gründerfonds . Rigontec, ...
Shares Of 'inversion' Candidates Slide On U.S. ... [Published Clusterstock - Sep 23 2014]
By Ben Hirschler and Dan Burns LONDON/NEW YORK (Reuters) - The U.S. Treasury's move to curb deals that allow U.S. companies to escape high taxes at home wiped a combined $12.3 billion off the shares of nearly a dozen companies on both sides of the ...
AstraZeneca, Shire Dive As U.S. Tax Move Punctu... [Published Clusterstock - Sep 23 2014]
By Ben Hirschler LONDON (Reuters) - Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. Treasury took steps to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad. The move ...
Research and Markets: Global Lysosomal Storage ... [Published Business Wire Health News - Aug 21 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5f7fvn/global_lysosomal) has announced the addition of the "Global Lysosomal Storage Diseases Market 2014-2018" report to their offering. The Global Lysosomal Storage ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
PatientsLikeMe and Actelion to Develop New Pati... [Published PatientsLikeMe Press Release - Aug 05 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.